Knowledge Hub
Immunology and Cell Therapy articles from GeneMedi.
In autoimmune research, regulatory T cells (Tregs) are generally regarded as the "brakes" that suppress excessive immune responses. However, a mouse study published in the Journal ...
Read article
Research Background Severe inflammatory lung disease, including acute respiratory distress syndrome (ARDS), has a high mortality rate and limited targeted therapeutic options. Rece...
Read article
In the randomized phase II ImmunoPRISM trial, patients with high-risk smoldering multiple myeloma received a fixed course of the BCMA×CD3 bispecific antibody teclistamab, achieving...
Read article
A phase 2 randomized trial shows that in people who started antiviral treatment early, two long-acting broadly neutralizing antibodies can delay viral rebound during an analytical ...
Read article
Tumor immunotherapy does not always work, and one often-overlooked reason lies at the starting point of the immune response. Dendritic cells (DCs) are responsible for presenting tu...
Read article
After infection and vaccination, whether the body can produce highly effective antibodies depends on whether B cells can "capture" antigens and present them to T cells. This proces...
Read article
The onset of autoimmune diseases arises from the immune system mistakenly attacking the body's own tissues. Regulatory T cells (Tregs) are the core cell population that maintains i...
Read article
More than 90% of adults carry Epstein-Barr virus (EBV) for life, yet rarely develop disease. But EBV is classified by the World Health Organization as a Group I carcinogen, associa...
Read article
Early diagnosis of cutaneous T-cell lymphoma (CTCL) has long been a challenge for dermatologists. This is especially true for the most common type, mycosis fungoides (MF), whose ea...
Read article
Chronic spontaneous urticaria (CSU) is a disease driven primarily by mast cells, manifesting as recurrent wheals, angioedema, or both. Approximately up to 1% of the global populati...
Read article
